-- 奥本海默周二发布的研究报告指出，由于商务旅行需求强劲，Navan (NAVN) 2027财年的业绩预期“极易实现”。报告还指出，Navan快速增长的人工智能平台加速了企业客户的拓展，提升了毛利率，并增强了旅客个性化服务。 分析师写道，尽管中东冲突和航空燃油价格高企，航空公司的商务旅行需求依然保持稳定。 该券商表示，Navan股票目前是其首选的中小市值股票。他们预计，企业客户的日益增长将推动业绩预期上调，而这一预期目前尚未反映在股价中，Navan的股价较同行折让60%。 报告称，Navan的虚拟代理负责大部分客户互动，并且是近年来毛利率增长的关键驱动力。 该券商重申了对Navan股票的“跑赢大盘”评级，并将目标价从17美元上调至20美元。
Price: $15.94, Change: $+0.59, Percent Change: +3.84%
Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.
SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.
Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.